CD9 and cerebral cavernous malformation: To ascertain the presence of nanoparticles expressing canonical sEV markers in our samples, an ELISA assay was performed to target the tetraspanin CD9 on sEVs from CCM from both cell lines grown in normoxic and hypoxic conditions (Figure 5A).